<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39142425</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>18</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1873-2585</ISSN><JournalIssue CitedMedium="Internet"><Volume>98</Volume><PubDate><Year>2024</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Annals of epidemiology</Title><ISOAbbreviation>Ann Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Risk factors for long COVID syndrome in postmenopausal women with previously reported diagnosis of COVID-19.</ArticleTitle><Pagination><StartPage>36</StartPage><EndPage>43</EndPage><MedlinePgn>36-43</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.annepidem.2024.08.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1047-2797(24)00214-X</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Long COVID-19 syndrome occurs in 10-20&#xa0;% of people after a confirmed/probable SARS-COV-2 infection; new symptoms begin within three months of COVID-19 diagnosis and last &gt;&#xa0;8 weeks. Little is known about risk factors for long COVID, particularly in older people who are at greater risk of COVID complications.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data are from Women's Health Initiative (WHI) postmenopausal women who completed COVID surveys that included questions on whether they had ever been diagnosed with COVID and length and nature of symptoms. Long COVID was classified using standard consensus criteria. Using WHI demographic and health data collected at study enrollment (1993-98) through the present day, machine learning identified the top 20 risk factors for long COVID. These variables were tested in logistic regression models.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of n&#xa0;=&#xa0;37,280 survey respondents, 1237 (mean age = 83 years) reported a positive COVID-19 test and 425 (30&#xa0;%) reported long COVID. Symptoms included an array of neurological, cardio-pulmonary, musculoskeletal, and general fatigue, and malaise symptoms. Long COVID risk factors included weight loss, physical and mobility limitations, and specific heath conditions (e.g., history of heart valve procedure, rheumatoid arthritis).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Knowledge of risk factors for long COVID may be the first step in understanding the etiology of this complex disease.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Neuhouser</LastName><ForeName>Marian L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Cancer Prevention Program, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, United States. Electronic address: mneuhous@fredhutch.org.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Butt</LastName><ForeName>Hamza Islam</ForeName><Initials>HI</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of AZ, Tucson, AZ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Chengcheng</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of AZ, Tucson, AZ, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shadyab</LastName><ForeName>Aladdin H</ForeName><Initials>AH</Initials><AffiliationInfo><Affiliation>Herbert Wertheim School of Public Health and Human Longevity Science and Division of Geriatrics, Gerontology and Palliative Care, Department of Medicine, University of California, La Jolla, San Diego, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia</LastName><ForeName>Lorena</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Public Health Sciences, Division of Epidemiology, University of California Davis School of Medicine, Davis, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Follis</LastName><ForeName>Shawna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Stanford Prevention Research Center, Stanford University, Stanford, CA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mouton</LastName><ForeName>Charles</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>Holly R</ForeName><Initials>HR</Initials><AffiliationInfo><Affiliation>Program in Epidemiology, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wactawski-Wende</LastName><ForeName>Jean</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Environmental Health, University at Buffalo, Buffalo NY, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gower</LastName><ForeName>Emily W</ForeName><Initials>EW</Initials><AffiliationInfo><Affiliation>Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vitolins</LastName><ForeName>Mara</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Wake Forest University School of Medicine, Department of Epidemiology and Prevention, Winston-Salem NC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Von Ah</LastName><ForeName>Diane</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>College of Nursing, The Ohio State University (OSU) &amp; Cancer Control Program, OSU Comprehensive Cancer Center, Columbus, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nassir</LastName><ForeName>Rami</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Pathology, School of Medicine, Umm Al-Quraa University, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karanth</LastName><ForeName>Shama</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Florida, Gainesville, FL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Ted</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Rush Institute for Healthy Aging, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paskett</LastName><ForeName>Electra</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Cancer Prevention and Control, Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, OH, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manson</LastName><ForeName>JoAnn E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zhao</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Mel and Enid Zuckerman College of Public Health, University of AZ, Tucson, AZ, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>75N92021D00002</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N92021D00005</GrantID><Acronym>WH</Acronym><Agency>WHI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN268201100046C</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N92021D00001</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N92021D00003</GrantID><Acronym>WH</Acronym><Agency>WHI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>UL1 TR001420</GrantID><Acronym>TR</Acronym><Agency>NCATS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>HHSN261201700010C</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>75N92021D00004</GrantID><Acronym>WH</Acronym><Agency>WHI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Ann Epidemiol</MedlineTA><NlmUniqueID>9100013</NlmUniqueID><ISSNLinking>1047-2797</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017698" MajorTopicYN="Y">Postmenopause</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Chronic disease</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Machine learning</Keyword><Keyword MajorTopicYN="N">Postmenopausal women</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Marian L Neuhouser reports financial support was provided by National Institutes of Health. Mara Vitolins reports financial support was provided by National Center for Advancing Translational Sciences. No other COI declared by any authors If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>11</Day><Hour>0</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>15</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>14</Day><Hour>19</Hour><Minute>17</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39142425</ArticleId><ArticleId IdType="mid">NIHMS2018926</ArticleId><ArticleId IdType="pmc">PMC11405002</ArticleId><ArticleId IdType="doi">10.1016/j.annepidem.2024.08.003</ArticleId><ArticleId IdType="pii">S1047-2797(24)00214-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022. Apr;22:e102&#x2013;e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, Neubauer S. Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J. 2022. Mar 14;43:1157&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Opsteen S, Files JK, Fram T, Erdmann N. The role of immune activation and antigen persistence in acute and long COVID. J Investig Med. 2023. Jun;71:545&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9996119</ArticleId><ArticleId IdType="pubmed">36879504</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Kelly JD, Lu S, Goldberg SA, Davidson MC, Mathur S, Durstenfeld MS, Spinelli MA, Hoh R, et al. Persistence, Magnitude, and Patterns of Postacute Symptoms and Quality of Life Following Onset of SARS-CoV-2 Infection: Cohort Description and Approaches for Measurement. Open Forum Infect Dis. 2022. Feb;9:ofab640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8755302</ArticleId><ArticleId IdType="pubmed">35106317</ArticleId></ArticleIdList></Reference><Reference><Citation>Samper-Pardo M, Le&#xf3;n-Herrera S, Oliv&#xe1;n-Bl&#xe1;zquez B, Gasc&#xf3;n-Santos S, S&#xe1;nchez-Recio R. Clinical characterization and factors associated with quality of life in Long COVID patients: Secondary data analysis from a randomized clinical trial. PLoS One. 2023;18:e0278728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10187923</ArticleId><ArticleId IdType="pubmed">37192203</ArticleId></ArticleIdList></Reference><Reference><Citation>Nandadeva D, Skow RJ, Stephens BY, Grotle AK, Georgoudiou S, Barshikar S, Seo Y, Fadel PJ. Cardiovascular and cerebral vascular health in females with postacute sequelae of COVID-19. Am J Physiol Heart Circ Physiol. 2023. Jun 1;324:H713&#x2013;h20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10151056</ArticleId><ArticleId IdType="pubmed">37000609</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandara T, Deshmukh HA, Abdalla M, Sathyapalan T. Metabolic and Endocrine Complications of Long-COVID-19: A Review. Exp Clin Endocrinol Diabetes. 2023. May 17.</Citation><ArticleIdList><ArticleId IdType="pubmed">36977491</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuodi P, Gorelik Y, Gausi B, Bernstine T, Edelstein M. Characterisation of post-COVID syndromes by symptom cluster and time period up to 12 months post-infection: A systematic review and meta-analysis. Int J Infect Dis. 2023. May 5.</Citation><ArticleIdList><ArticleId IdType="pubmed">37150350</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson EJ, Williams DM, Walker AJ, Mitchell RE, Niedzwiedz CL, Yang TC, Huggins CF, Kwong ASF, Silverwood RJ, et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022. Jun 28;13:3528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C, Zurbuchen Y, Taeschler P, Ballouz T, Menges D, Hasler S, Adamo S, Raeber ME, B&#xe4;chli E, et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat Commun. 2022. Jan 25;13:446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, Ng RH, Wang K, Choi J, Li S, Hong S, Zhang R, et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022. Mar 3;185:881&#x2013;95.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Righi E, Mirandola M, Mazzaferri F, Dossi G, Razzaboni E, Zaffagnini A, Ivaldi F, Visentin A, Lambertenghi L, et al. Determinants of persistence of symptoms and impact on physical and mental wellbeing in Long COVID: A prospective cohort study. J Infect. 2022. Apr;84:566&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8828388</ArticleId><ArticleId IdType="pubmed">35150765</ArticleId></ArticleIdList></Reference><Reference><Citation>Pel&#xe0; G, Goldoni M, Solinas E, Cavalli C, Tagliaferri S, Ranzieri S, Frizzelli A, Marchi L, Mori PA, et al. Sex-Related Differences in Long-COVID-19 Syndrome. J Womens Health (Larchmt). 2022. May;31:620&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaweethai T, Jolley SE, Karlson EW, Levitan EB, Levy B, McComsey GA, McCorkell L, Nadkarni GN, Parthasarathy S, et al. Development of a Definition of Postacute Sequelae of SARS-CoV-2 Infection. JAMA. 2023. 329 (22):1934&#x2013;1946</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10214179</ArticleId><ArticleId IdType="pubmed">37278994</ArticleId></ArticleIdList></Reference><Reference><Citation>WHI. Design of the Women&#x2019;s Health Initiative clinical trial and observational study. The Women&#x2019;s Health Initiative Study Group. Control Clin Trials. 1998;19:61&#x2013;109.</Citation><ArticleIdList><ArticleId IdType="pubmed">9492970</ArticleId></ArticleIdList></Reference><Reference><Citation>Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang CY, Stein E, Prentice RL. Implementation of the Women&#x2019;s Health Initiative study design. Ann Epidemiol. 2003. Oct;13:S5&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">14575938</ArticleId></ArticleIdList></Reference><Reference><Citation>  https://towardsdatascience.com/be-careful-when-interpreting-your-features-importance-in-xgboost-6e16132588e7.</Citation></Reference><Reference><Citation>DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988. Sep;44:837&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>vanBuuren S, Groothuis-Oudshoorn K. Multivariate Imputation by Chained Equations in R. Journal of statistical software. 2011;45:1&#x2013;67.</Citation></Reference><Reference><Citation>Robin X, Turck N, Hainard A, Tiberti N, Lisacek F, Sanchez JC, M&#xfc;ller M. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics. 2011. Mar 17;12:77.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3068975</ArticleId><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuhn M. _caret: Classification and Regression Training_R package version 6.0-93. 2022.  [cited; Available from: https://CRAN.R-project.org/package=caret</Citation></Reference><Reference><Citation>Chen T, He T, Benesty M, Khotilpvich V, Tang Y, Cho H, Chen K, R. M, Cano I, et al.
xgboost: Extreme Gradient Boosting. R package version 1.6.0.1. 2022.  [cited; Available from: https://CRAN.R-project.org/package=xgboost</Citation></Reference><Reference><Citation>Lynch SM, Guo G, Gibson DS, Bjourson AJ, Rai TS. Role of Senescence and Aging in SARS-CoV-2 Infection and COVID-19 Disease. Cells. 2021. Nov 30;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8699414</ArticleId><ArticleId IdType="pubmed">34943875</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanbehzadeh S, Zanjari N, Yassin M, Yassin Z, Tavahomi M. Association between long COVID, functional activity, and health-related quality of life in older adults. BMC Geriatr. 2023. Jan 23;23:40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9868494</ArticleId><ArticleId IdType="pubmed">36690948</ArticleId></ArticleIdList></Reference><Reference><Citation>Prendki V, Tiseo G, Falcone M. Caring for older adults during the COVID-19 pandemic. Clin Microbiol Infect. 2022. Jun;28:785&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8912971</ArticleId><ArticleId IdType="pubmed">35283306</ArticleId></ArticleIdList></Reference><Reference><Citation>Tiseo G, Yahav D, Paul M, Tinelli M, Gavazzi G, Mussini C, Prendki V, Falcone M. What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group. Eur J Clin Microbiol Infect Dis. 2022. Feb;41:281&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8590524</ArticleId><ArticleId IdType="pubmed">34775534</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauria A, Carf&#xec; A, Benvenuto F, Bramato G, Ciciarello F, Rocchi S, Rota E, Salerno A, Stella L, et al. Neuropsychological Measures of Long COVID-19 Fog in Older Subjects. Clin Geriatr Med. 2022. Aug;38:593&#x2013;603.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9080120</ArticleId><ArticleId IdType="pubmed">35868675</ArticleId></ArticleIdList></Reference><Reference><Citation>Daitch V, Yelin D, Awwad M, Guaraldi G, Mili&#x107; J, Mussini C, Falcone M, Tiseo G, Carrozzi L, et al. Characteristics of long-COVID among older adults: a cross-sectional study. Int J Infect Dis. 2022. Dec;125:287&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">36191820</ArticleId></ArticleIdList></Reference><Reference><Citation>Yellumahanthi DK, Barnett B, Barnett S, Yellumahanthi S. COVID-19 Infection: Its Lingering Symptoms in Adults. Cureus. 2022. May;14:e24736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9166577</ArticleId><ArticleId IdType="pubmed">35677013</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung KW, Baye F, Baik SH, Zheng Z, McDonald CJ. Prevalence and characteristics of long COVID in elderly patients: An observational cohort study of over 2 million adults in the US. PLoS Med. 2023. Apr;20:e1004194.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10150975</ArticleId><ArticleId IdType="pubmed">37068113</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, Clark A, Ntatsaki E, Vassiliou VS. Risk Factors Associated With Post-COVID-19 Condition: A Systematic Review and Meta-analysis. JAMA Intern Med. 2023. Jun 1;183:566&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10037203</ArticleId><ArticleId IdType="pubmed">36951832</ArticleId></ArticleIdList></Reference><Reference><Citation>VoPham T, Harris HR, Tinker LF, Manson JE, Meliker JR, Wassertheil-Smoller S, Shadyab AH, Saquib N, Anderson GL, Shumaker SA. The Impact of the COVID-19 Pandemic on Older Women in the Women&#x2019;s Health Initiative. J Gerontol A Biol Sci Med Sci. 2022. Dec 6;77:S3&#x2013;s12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9383531</ArticleId><ArticleId IdType="pubmed">35238375</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang C, Hou Y, Schenck EJ, Xu Z, Zhang Y, Xu J, Bian J, Morozyuk D, Khullar D, et al. Identification of risk factors of Long COVID and predictive modeling in the RECOVER EHR cohorts. Commun Med (Lond). 2024. Jul 11;4:130.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11239808</ArticleId><ArticleId IdType="pubmed">38992068</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashmawy R, Hammouda EA, El-Maradny YA, Aboelsaad I, Hussein M, Uversky VN, Redwan EM. Interplay between Comorbidities and Long COVID: Challenges and Multidisciplinary Approaches. Biomolecules. 2024. Jul 11;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11275036</ArticleId><ArticleId IdType="pubmed">39062549</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T, Sivan M, Perlowski A, Nikolich J. Long COVID: a clinical update. Lancet. 2024. Jul 31.</Citation><ArticleIdList><ArticleId IdType="pubmed">39096925</ArticleId></ArticleIdList></Reference><Reference><Citation>Strongin SR, Stelson E, Soares L, Sukhatme V, Dasher P, Schito M, Challa AP, Geng LN, Walker TA. Using real-world data to accelerate the search for long COVID therapies. Life Sci. 2024. Aug 2:122940.</Citation><ArticleIdList><ArticleId IdType="pubmed">39098596</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>